Diluted EPS came in at $-0.70 (+53.3% YoY), beat the $-0.73 consensus by $0.03.
Trailing eight quarters through Q1 2026
Common questions about BioVie, Inc.'s Q1 2026 earnings report.
BioVie, Inc. (BIVI) reported Q1 2026 earnings on May 11, 2026 after market close.
BioVie, Inc. reported diluted EPS of $-0.70 for Q1 2026.
EPS beat the consensus estimate of $-0.73 by $0.03.
Compared to the same quarter a year prior, diluted EPS grew 53.3% from $-1.50.
You can read the 10-Q periodic report (0001520138-26-000154) directly on SEC EDGAR. The filing index links above go to sec.gov.